Daniel Alexander Leffler, M.D.
This page shows the publications co-authored by Daniel Leffler and Amelie Therrien.
Editorial: coeliac disease-it's a family affair. Aliment Pharmacol Ther. 2021 10; 54(7):967-968.
Gluten immunogenic peptides: is knowing half the battle? Am J Clin Nutr. 2020 11 11; 112(5):1147-1148.
Enteric-Release Budesonide May Be Useful in the Management of Non-Responsive Celiac Disease. Dig Dis Sci. 2021 06; 66(6):1989-1997.
Efficacy of Enteric-Release Oral Budesonide in Treatment of Acute Reactions to Gluten in Patients With Celiac Disease. Clin Gastroenterol Hepatol. 2020 01; 18(1):254-256.
Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease. Nat Rev Gastroenterol Hepatol. 2021 12; 18(12):875-884.
Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study. Aliment Pharmacol Ther. 2021 11; 54(10):1278-1289.
Non-responsive celiac disease in children on a gluten free diet. World J Gastroenterol. 2021 Apr 07; 27(13):1311-1320.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.